AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Bavarian Nordic

Director's Dealing Apr 24, 2022

3354_rpt_2022-04-24_d62a175d-3387-4a5e-8457-721bebfc6a53.html

Director's Dealing

Open in Viewer

Opens in native device viewer

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such

COPENHAGEN, Denmark, April 24, 2022 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.

The transactions concern the vesting of restricted stock units (RSUs) awarded to members of the Board of Directors of Bavarian Nordic A/S as part of their remuneration for 2019, and in accordance with the decision by the Annual General Meeting on April 24, 2019. The three-year vesting period has now expired, and all conditions for release of the shares have been met.

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Gerard van Odijk
2. Reason for the notification
a) Position/status Chairman of the Board of Bavarian Nordic A/S
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Bavarian Nordic A/S
b) LEI 2138006JCDVYIN6INP51
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument





Identification code
Shares





DK0015998017
b) Nature of the transaction Acquisition of shares (vesting of restricted stock units)
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 109.36 3,429
d) Aggregated information

- Aggregated volume
- Price
3,429

DKK 375,000.00
e) Date of the transaction 2022-04-24
f) Place of the transaction Outside a trading venue
1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Anders Gersel Pedersen
2. Reason for the notification
a) Position/status Deputy Chairman of the Board of Bavarian Nordic A/S
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Bavarian Nordic A/S
b) LEI 2138006JCDVYIN6INP51
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument





Identification code
Shares





DK0015998017
b) Nature of the transaction Acquisition of shares (vesting of restricted stock units)
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 109.44 2,056
d) Aggregated information

- Aggregated volume
- Price
2,056

DKK 225,000.00
e) Date of the transaction 2022-04-24
f) Place of the transaction Outside a trading venue
1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Peter Kürstein
2. Reason for the notification
a) Position/status Member of the Board of Bavarian Nordic A/S
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Bavarian Nordic A/S
b) LEI 2138006JCDVYIN6INP51
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument





Identification code
Shares





DK0015998017
b) Nature of the transaction Acquisition of shares (vesting of restricted stock units)
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 109.41 1,371
d) Aggregated information

- Aggregated volume
- Price
1,371

DKK 150,000.00
e) Date of the transaction 2022-04-24
f) Place of the transaction Outside a trading venue
1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Frank Verwiel
2. Reason for the notification
a) Position/status Member of the Board of Bavarian Nordic A/S
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Bavarian Nordic A/S
b) LEI 2138006JCDVYIN6INP51
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument





Identification code
Shares





DK0015998017
b) Nature of the transaction Acquisition of shares (vesting of restricted stock units)
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 109.41 1,371
d) Aggregated information

- Aggregated volume
- Price
1,371

DKK 150,000.00
e) Date of the transaction 2022-04-24
f) Place of the transaction Outside a trading venue
1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Elizabeth McKee Anderson
2. Reason for the notification
a) Position/status Member of the Board of Bavarian Nordic A/S
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Bavarian Nordic A/S
b) LEI 2138006JCDVYIN6INP51
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument





Identification code
Shares





DK0015998017
b) Nature of the transaction Acquisition of shares (vesting of restricted stock units)
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 109.41 1,371
d) Aggregated information

- Aggregated volume
- Price
1,371

DKK 150,000.00
e) Date of the transaction 2022-04-24
f) Place of the transaction Outside a trading venue
1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Anne Louise Eberhard
2. Reason for the notification
a) Position/status Member of the Board of Bavarian Nordic A/S
b) Initial notification/Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Bavarian Nordic A/S
b) LEI 2138006JCDVYIN6INP51
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument





Identification code
Shares





DK0015998017
b) Nature of the transaction Acquisition of shares (vesting of restricted stock units)
c) Price(s) and volume(s) Price(s) Volume(s)
DKK 109.41 1,371
d) Aggregated information

- Aggregated volume
- Price
1,371

DKK 150,000.00
e) Date of the transaction 2022-04-24
f) Place of the transaction Outside a trading venue

About Bavarian Nordic

Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacturing and commercialization of life-saving vaccines. We are a global leader in smallpox vaccines and have been a long-term supplier to the U.S. Government of a non-replicating smallpox vaccine, which has been approved by the FDA, also for the protection against monkeypox. The vaccine is approved as a smallpox vaccine in Europe and Canada. Our commercial product portfolio furthermore contains market-leading vaccines against rabies and tick-borne encephalitis. Using our live virus vaccine platform technology, MVA-BN®, we have created a diverse portfolio of proprietary and partnered product candidates designed to save and improve lives by unlocking the power of the immune system, including an Ebola vaccine, which is licensed to the Janssen Pharmaceutical Companies of Johnson & Johnson. We are also committed to the development of a next generation COVID-19 vaccine. For more information visit www.bavarian-nordic.com.

Contacts

Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43

US: Graham Morrell, Paddock Circle Advisors, [email protected], Tel: +1 781 686 9600

Company Announcement no. 12 / 2022

Attachment

Talk to a Data Expert

Have a question? We'll get back to you promptly.